In both in vitro and in vivostudies, they validated the anti-UC properties of Se-CA, findingthat Se-CA significantly improves colonic pathology in colitis miceby enhancing epithelial repair, reducing inflammation, reversingmacrophage type 1 responses, and decreasing reactive oxygenspecies (ROS) levels